By Thomas Dobrow Integra Lifesciences Holdings Corp (NASDAQ:IART)‘s stock had its “buy” rating reissued by equities researchers at Piper Jaffray in a research note issued on Thursday, ARN reports. A number of other research analysts have also issued reports on the stock. Lake Street